Movement disorders in neuroleptic-naïve patients with schizophrenia spectrum disorders

BMC Psychiatry

Volumn 14, Issue 1, 2014, Pages

  Ayehu, Moges ^a   Shibre, Teshome ^b,c   Milkias, Barkot ^b   Fekadu, Abebaw ^b,d  

^a HAWASSA UNIVERSITY   (Ethiopia)

^b ADDIS ABABA UNIVERSITY   (Ethiopia)

^c UNIVERSITY OF TORONTO   (Canada)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Antipsychotics; Developing country; Dyskinesia; Dyskinetic movements; Ethiopia; Parkinsonism; Psychotic disorder; Schizoaffective disorder; Schizophrenia; Schizophreniform disorder; Spontaneous movement disorders

Indexed keywords

ABNORMAL INVOLUNTARY MOVEMENT SCALE; ADULT; ARTICLE; BODY MASS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ETHIOPIA; FEMALE; HEALTH SURVEY; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; POSITIVE AND NEGATIVE SYNDROME SCALE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SIMPSON ANGUS RATING SCALE; SPONTANEOUS MOVEMENT DISORDER; ADOLESCENT; COMPLICATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOSIS; YOUNG ADULT;

NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; CROSS-SECTIONAL STUDIES; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOVEMENT DISORDERS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84908103509     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/s12888-014-0280-1     Document Type: Article

References (49)

1. Gerlach J, Casey D. Tardive dyskinesia. Acta Psychiatr Scand 1988, 77:369-378. 10.1111/j.1600-0447.1988.tb05138.x, 2898870.
2. Kane J, Woerner M, Lieberman J. Tardive dyskinesia: rate incidence and risk factors, in Dyskinesia Research and Treatment 1985, Springer, Berlin.
3. Kane J, Smith J. Tardive dyskinesia: rate and risk factors. Arch Gen Psychiatry 1982, 39:473-481. 10.1001/archpsyc.1982.04290040069010, 6121548.
4. McCreadie R, Strinivasan T, Padmavati R, Thara R. Extrapyramidal Symptoms in un medicated schizophrenia. J Psychiatr Research 2005, 39:261-266. 10.1016/j.jpsychires.2004.08.002.
5. Pappa S, Dazzan P. Spontaneous movement disorders in antipsychotic-native patients with first-episode psychoses: a systematic review. Psychol Med 2009, 39:1065-1076. 10.1017/S0033291708004716, 19000340.
6. Whitty P, Owoeye O, Waddington J. Neurological Signs and Involuntry Movements in Schizophrenia: Intrinsic To and Informative on Systems Pathobiology. Schizophr Bull 2009, 35:415-424. 10.1093/schbul/sbn126, 18791074.
7. Kraepelin E. Dementia praecox and paraphrenia 1919, Edinburgh, E & S Livingstone.
8. Turner T. Rich and mad in Victorian England. Psychol Med 1989, 19:29-44. 10.1017/S0033291700011004, 2657831.
9. Liddle P. Tardive dyskinesia in schizophrenia. Br J Psychiatry 2013, 203:6-7. 10.1192/bjp.bp.112.123679, 23818532.
10. Sarro S, Pomarol-Clotet E, Canales-Rodriguez EJ, Salvador R, Gomar JJ, Ortiz-Gil J, Landin-Romero R, Vila-Rodriguez F, Blanch J, McKenna PJ. Structural brain changes associated with tardive dyskinesia in schizophrenia. Br J Psychiatry 2013, 203:51-57. 10.1192/bjp.bp.112.114538, 23222039.
11. Caligiuri M, Lohr J. A disturbance in the control of muscle force in neuroleptic-natve schizophrenic patients. Biol Psychiatry 1994, 35:104-111. 10.1016/0006-3223(94)91199-1, 7909452.
12. Chatterjee A, Chakos M, Koreen A. Prevalence and clinnical correlates of extrapyra midal signs and spontaneous dyskinesia in never-medicated schizophrenic patients. Am J Psychiatry 1995, 152:1724-1729. 8526237.
13. McCreadie R, Thara R, Kamath S. Abnormal movements in never-medicated Indian patients with schizophreniz. Br J Psychiatry 1996, 168:221-226. 10.1192/bjp.168.2.221, 8837914.
14. Fenton W, Wyatt R, McGlashan T. Risk factors for spontaneous dyskinesia in schizophrenia. Arch Gen Psychiatry 1994, 51:643-650. 10.1001/archpsyc.1994.03950080055008, 8042913.
15. Guy W. ECDEU assessment manual for psychopharmacology 1976, US Department of Health, Education and Welfare, Washington, DC.
16. Gervin M, Browene S, Lane A. Spontaneous abnormal involuntary movements in first-episode schizophr-enia and schizophreniform disorder: baseline rate in a group of patients from an Irish catchment area. Am J Psychiatry 1998, 155:1202-1206. 9734543.
17. Puri B, Barnes T, Chapman M, Hutton S, Joyce E. Spontaneous dyskinsesia in first episode schizophrenia. J Neurol Neurosurg Psychiatry 1999, 66:76-78. 10.1136/jnnp.66.1.76, 9886457.
18. Caligiuri M, Lohr J, Jeste D. Parkinsonism in neurolptic-naive schizophrenic patients. Am J Psychiatry 1993, 150:1343-1348. 8352344.
19. Fenn D, Moussaoui D, Hoffman W. Movements in never-medicated schizophrenics. Psychopharmacology 1996, 123:206-210. 10.1007/BF02246179, 8741945.
20. Kopala L, Good K, Honer W. Extrapyramidddal signs and clinical symptoms in first-episode schizophrenia: response to low-dose risperidone. J Clin Psychopharamacology 1997, 17:308-313. 10.1097/00004714-199708000-00011.
21. Peralta V, Cuesta M, Martinez-Larrea A, Serrano J. Differnetiating primary from secondary negative symptoms in schizophrenia. Am J Psychiatry 2000, 157:1461-1466. 10.1176/appi.ajp.157.9.1461, 10964863.
22. Honer W, Kopala L, Rabinowitz J. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness. J Psychopharmacology 2005, 19:277-285. 10.1177/0269881105051539.
23. Shawn L, Cassady M, Helene A. Spontaneous Dyskinesia in Subjects with Schizophrenia Spectrum Personality. Am J Psychiatry 1998, 155:70-7563.
24. Jeroen P, Diederik E, Jim V, Andrr A, Renr S, Peter N. Dyskinesia and Paarkinsonism in Antipsychotic-Native Patients With Schizophrenia, First-Degree Relatives and Healthy Controls. A Meta-analysis. Schizophr Bull 2010, 36:723-731. 10.1093/schbul/sbn146.
25. Fenton W. Prevalence of spontaneous dyskinesia in schizophrenia. J Clin Psychiatry 2000, 61(Suppl. 4):10-14. 10739325.
26. Cortese L, Caligiuri M, Malla A, Manchanda R, Takhar J, Haricharan R. Relationship of neuromotor disturbances to psychosis symptoms in first-episode neuroleptic-naive schizophrenia patients. Schizophr Res 2005, 75:65-75. 10.1016/j.schres.2004.08.003, 15820325.
27. Pareek P, Bhojraj T, Montrose D, Rajarethinam R, Sweeney J, Keshava M. Involuntary movements and their correlates in first-episode psychoses. Acta Neuropsychiatr 2010, 22(5):262-263. 10.1111/j.1601-5215.2010.00484.x, 21892250.
28. McCreadie R, Latha S, Thara R, Padmavati R, Ayankaran J. Poor memory, negative symptoms and abnormal movements in never-treated Indian patients with schizophrenia. Br J Psychiatry 1997, 171:360-363. 10.1192/bjp.171.4.360, 9373426.
29. Sandyk R, Kay S. The relationship of tardive dyskinesia to postive schizophrenia. Int J Neurosci 1991, 56:107-139. 10.3109/00207459108985409, 1938127.
30. White T, Brown K, Woods J. Tardive dyskinesia and positive symptoms of schizophrenia. Acta Psychiatri Scand 1991, 83:377-379. 10.1111/j.1600-0447.1991.tb05559.x.
31. Waddington J, Youssef H, Dolphin C, Kinsella A. Cognitive dysfunction, negative symptoms, and tardive dyskinesia in schizophrenia. Their association in relation to topography of involuntary movements and criterion of their abnormality. Arch Gen Psychiatry 1987, 44:907-912. 10.1001/archpsyc.1987.01800220077011, 2889438.
32. Yarden P, DiScipio W. Abnormal movements and prognosis in schizophrenia. Am J Psychiatry 1971, 128:317-323. 5570997.
33. Crown T, Cross A, Johnstone E, Owen F, Owens D, Waddington J. Abnormal involuntary movements in schizophrenia: are they related to the disease process or its treatment? Are they associated with changes in dopamine receptors. J Clin Psychopharamacology 1982, 2:336-340.
34. Rogers D. The motor disorders of severe psychiatric illness: a conflict of paradigms. Br J Psychiatry 1985, 147:221-232. 10.1192/bjp.147.3.221, 2866007.
35. Fekadu A, Kebede D, Alem A, Fekadu D, Mogga S, Negash A, Medhin G, Beyero T, Shibre T. Clinical outcome in bipolar disorder in a community-based follow-up study in Butajira, Ethiopia. Acta Psychiatr Scand 2006, 114(6):426-434. 10.1111/j.1600-0447.2006.00825.x, 17087791.
36. Kebede D, Alem A, Shibre T, Negash A, Fekadu A, Fekadu D, Deyassa N, Jacobsson L, Kullgren G. Onset and clinical course of schizophrenia in Butajira-Ethiopia-a community-based study. Soc Psychiatry Psychiatr Epidemiol 2003, 38(11):625-631. 10.1007/s00127-003-0678-4, 14614550.
37. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text revision 2000, American Psychiatric Association, Washington, DC.
38. Simpson G, Angus J. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 1970, 212:S11-S19. 10.1111/j.1600-0447.1970.tb02066.x.
39. Guy W. ECDEU Assessment Manual for Psychopharmacology. Revised DHEW Pub. (ADM) 1976, Rockville, MD, National Institute for Mental Health. Psychopharmacology Resrarch.
40. Schooler N, Kamath J. Research diagnoses for tardive dyskinesia(letter). Arch Gen Psychiatry 1982, 39:486-487. 6121550.
41. Andreasen N. Scale for the Assessment of Positive Symptoms (SAPS) 1984, Iowa City, Unversity of IOWA.
42. Andreasen N. Modified Scale for the Assessment of Negative Symptoms (SANS) 1984, University of Iowa, Iowa City.
43. The use and interpretation of anthropometry: report of a WHO expert committee. WHO Technical Report Series 854 1995, World Health Organization, Geneva.
44. Hibbeln J, Davis J, Steer C. Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study. Lancet 2007, 369(9561):578-585. 10.1016/S0140-6736(07)60277-3, 17307104.
45. Koenen K, Moffitt T, Roberts A. Childhood IQ and adult mental disorders: a test of the cognitive reserve hypothesis. Am J Psychiatry 2009, 166(1):50-57. 10.1176/appi.ajp.2008.08030343, 19047325.
46. Horrobin D. The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophr Res 1998, 30(3):193-208. 10.1016/S0920-9964(97)00151-5, 9589514.
47. Fenton W, Hibbeln J, Knable M. Essential fatty acids, lipid membrance abnormalities, and the diagnosis and treatment of schizophrenia. Biol Psychiatry 2000, 47(1):8-21. 10.1016/S0006-3223(99)00092-X, 10650444.
48. Hedelin M, Luf M. Dietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33000 women from the general populaation. BMC Psychiatry 2010, 10:38. 10.1186/1471-244X-10-38, 20504323.
49. Merrill RM, Lyon JL, Matiaco PM. Tardive and spontaneous dyskinesia incidence in the general population. BMC Psychiatry 2013, 13:152. 10.1186/1471-244X-13-152, 23714238.